DrugPatentWatch Database Preview

Valeant Intl Company Profile

VALEANT INTL has thirteen approved drugs.

There are three US patents protecting VALEANT INTL drugs.

There are twenty patent family members on VALEANT INTL drugs in eleven countries and thirty supplementary protection certificates in twelve countries.

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Valeant Intl	ATIVAN	lorazepam	TABLET;ORAL	017794-002	Approved Prior to Jan 1, 1982	AB	RX	Yes	No		➤ Sign Up				➤ Sign Up
Valeant Intl	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-006	Feb 6, 2003	AB	RX	Yes	Yes	6,923,984	➤ Sign Up	Y			➤ Sign Up
Valeant Intl	HYTONE	hydrocortisone	CREAM;TOPICAL	080472-004	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Valeant Intl	CARDIZEM LA	diltiazem hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021392-003	Feb 6, 2003	AB	RX	Yes	No	7,108,866	➤ Sign Up	Y			➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Intl	WELLBUTRIN XL	bupropion hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021515-002	Aug 28, 2003	6,143,327	➤ Sign Up
Valeant Intl	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-001	Aug 10, 1992	5,364,620	➤ Sign Up
Valeant Intl	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-005	Aug 24, 1999	5,439,689	➤ Sign Up
Valeant Intl	CARDIZEM CD	diltiazem hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	020062-004	Dec 27, 1991	4,894,240	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Gel	0.1%	➤ Subscribe	2010-07-08
➤ Subscribe	Extended-release Tablets	120 mg, 180 mg, 240 mg, 300 mg and 360 mg	➤ Subscribe	2005-08-30
➤ Subscribe	Extended-release Tablets	150 mg and 300 mg	➤ Subscribe	2004-09-21
➤ Subscribe	Gel	0.04%	➤ Subscribe	2010-12-20
➤ Subscribe	Extended-release Tablets	420 mg	➤ Subscribe	2005-04-25

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0918	Netherlands	➤ Sign Up	PRODUCT NAME: NALTREXON OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER NALTREXONHYDROCHLORIDE, EN BUPROPION OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, IN HET BIJZONDER BUPROPIONHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/14/988 20150330
2008 00029	Denmark	➤ Sign Up	PRODUCT NAME: ADAPALEN, BENZOYLPEROXID
/2000	Austria	➤ Sign Up	PRODUCT NAME: BUPROPION HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-23680 20000616; FIRST REGISTRATION: NL 24160 19991201
C0038	France	➤ Sign Up	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.